Figure 1:
Figure 1:. Mean of the median fluorescence ratios (MFR) for components of the AKT/Bcl-xL signal transduction pathway during the first two weeks of Eltrombopag treatment.

Mean of the median fluorescence ratios (MFR) for components of the AKT/Bcl-xL signal transduction pathway during the first two weeks of Eltrombopag treatment.

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal